FINAL RESULTS: BOND-003 COHORT C- PHASE 3, SINGLE-ARM STUDY OF INTRAVESICAL CRETOSTIMOGENE GRENADENOREPVEC FOR HIGH-RISK BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU
Mark D. Tyson, Edward Uchio, Jong-Kil Nam, Shreyas Joshi, Trinity J. Bivalacqua, Gary D. Steinberg, Hiroshi Kitamura, Ben Tran, Roger Li
Topics & Concepts
MedicineBladder cancerCarcinoma in situCohortUrologyOncologyInternal medicineCancerBladder and Urothelial Cancer Treatments